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26 Attachment of ubiquitin to proteins represents a central mechanism for the regulation of protein metabolism
27 and function. In the NF-kappaB pathway, binding of NEMO to polyubiquitinated substrates initiates the
28 pathway in response to cellular stimuli. Other polyubiquitin binding proteins can antagonize this pathway by
29 competing with NEMO for polyubiquitin. We have used protein arrays to identify polyubiquitin binding
30 proteins that regulate NF-kappaB activity. Using polyubiquitin as bait, protein arrays were screened and
31 polyubiquitin binders identiﬁed. Novel polyubiquitin binders AWP1, CALCOCO2, N4BP1, RIO3, TEX27, TTC3,
32 UBFD1 and ZNF313 were identiﬁed using this approach, while known NF-kappaB regulators including NEMO,
33 A20, ABIN-1, ABIN-2, optineurin and p62 were also identiﬁed. Overexpressed AWP1 and RIO3 repressed NF-
34 kappaB activity in a manner similar to optineurin, while siRNAs directed against AWP1 and RIO3 also reduced
35 NF-κB activity. TNFalpha-dependent degradation of IkappaBalpha was also suppressed by overexpression of
36 AWP1 and RIO3, possibly due to the polyubiquitin binding activity of these proteins. Protein array screening
37 using polyubiquitin enabled rapid identiﬁcation of many known and novel polyubiquitin binding proteins
38 and the identiﬁcation of novel NF-kappaB regulators.
39 © 2009 Elsevier B.V. All rights reserved.
40
41
42
43
44 1. Introduction
45 In recent years, the importance of polyubiquitin as a signaling
46 molecule has come to the forefront of biochemical signaling research.
47 The landmark discovery that the NF-κB signaling component NEMO
48 (NF-κB essential modiﬁer) is recruited to activated TNF (Tumor Ne-
49 crosis Factor) receptor complexes by its interaction with K63-linked
50 polyubiquitin chains [1] altered the perception that polyubiquitina-
51 tion was synonymous with proteosomal protein degradation. In the
52 TNF pathway, ubiquitin monomers are ligated to form K63-linked
53 polyubiquitin on the RIP (receptor interacting protein) scaffold
54 protein, enabling NEMO to recruit IKK (inhibitor of κB kinase) kinases
55 to the complex and initiate the NF-κB signaling cascade [2–4].
56 NEMO binds to polyubiquitin via a domain termed NUB (NEMO
57 ubiquitin binding), which is located in the C-terminal region of the
58 protein [2,5]. Unlike the common zinc ﬁnger ubiquitin binding domain
59 [6], theNUBdomain is rare amonghumanproteins, and thus farhas only
60 been identiﬁed in NEMO and several functionally related proteins [7,8].
61 Recently, a number of works have demonstrated that the
62 recruitment of NEMO to the TNF receptor complex is antagonized by
63 other polyubiquitin binding proteins that modulate TNF signaling in
64 response to secondary stimuli. One of the best examples of such a
65 protein is optineurin, expressed in retinal ganglia and associated with
66glaucoma, which competes with NEMO to dampen NF-κB signaling
67[8]. Optineurin binds polyubiquitin via a domain very closely related
68to the NUB domain. The ABIN proteins also antagonize NF-κB signaling
69through polyubiquitin binding via a structurally similar domain [7].
70These recent ﬁndings suggest that there may be other polyubiquitin
71binding proteins that regulate NF-κB signaling in response to different
72cellular and environmental cues.
73In the current study, we have used membrane-based colony
74macroarrays to screen for human polyubiquitin binding proteins, with
75the aim of identifying novel proteins that possess new polyubiquitin
76binding domains and that can inﬂuence NF-κB signaling. In this screen
77we used human ubiquitin C (UbC), an ubiquitin precursor that contains
78nine head-to-tail repeats of ubiquitin, as a probe for polyubiquitin
79binding proteins. This approach enabled us to identify 31 polyubiquitin
80binding proteins, ofwhich eight: AWP1, CALCOCO2, N4BP1, RIO3, TEX27,
81TTC3, UBFD1 and ZNF313, are novel interactors not previously known to
82bind polyubiquitin. Of these novel interactors, we show that AWP1 and
83RIO3 inﬂuence NF-κB-dependent transcriptional activation in human
84cells and thus serve as novel regulators of this pathway.
852. Materials and methods
862.1. Protein expression and puriﬁcation
87Human ubiquitin C and NEMO were expressed as soluble GST
88fusions from pGEX-4T-3 in E. coli BL21 (DE3) and puriﬁed using
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89 glutathione sepharose (GE Life Sciences) according to the manufac-
90 turer's instructions. Polyhistidine-tagged proteins were expressed
91 from pQE30 in E. coli XL1 Blue cells and puriﬁed using nickel-NTA
92 resin (Qiagen).
93 2.2. Colony array screening
94 Membrane-based colony macroarrays were obtained from Ima-
95 Genes (Berlin, Germany). Arrays consisted of cDNAs from human
96 brain, colon, liver and lung expressed from pQE30 as His6 fusions in
97 PVDFmembrane-immobilized E. coli XL Blue colonies. Array screening
98 with GST, GST-UbC and anti-GST-HRP (GE Life Sciences) was
99 performed as described previously [9].
100 2.3. Protein dot blots.
101 Solutions of puriﬁed GST, GST-UbC, monoubiquitin, K48-linked
102 polyubiquitin and K63-linked polyubiquitin (Boston Biochem) were
103 spotted in 0.1 μg (GST-UbC) or 1 μg (all other proteins) onto
104 nitrocellulose membranes and dried at room temperature for
105 15 min. Membranes were blocked in PBS-T containing 5% BSA for
1061 h, then probed with 20 μg of each puriﬁed protein and washed as
107described for the arrays. Binding was detected using anti-RGS-His
108(Qiagen) diluted 1:1000 followed by rabbit anti-mouse HRP conjugate
109(Millipore) diluted 1:1000, or anti-GST-HRP (GE Life Sciences) diluted
1101:1000. Signals were detected as described for the arrays.
1112.4. Pulldown of ubiquitin-binding proteins
112Human embryonic kidney cells (HEK-293T) were transfected using
113Lipofectamine 2000 (Invitrogen) as recommended by the manufac-
114turer. Plasmids encoding NEMO, N4BP1, TEX27 and ZNF313 were used
115for HEK-293T transfection, while endogenous AWP1, CALCOCO2, RIO3
116and TTC3 were detected in HEK-293T cell extracts. GST pulldowns
117were performed as described previously [10] and immunoblots
118probed with anti-Xpress (Invitrogen), anti-Myc (Santa Cruz Biotech)
119or protein-speciﬁc antibodies (Santa Cruz Biotech).
1202.5. NF-κB reporter gene assays
121Transcriptional activation by NF-κB was monitored using a
122secreted alkaline phosphatase (SEAP) reporter plasmid, pNF-κB-
Fig. 1. Screening colony macroarrays with human ubiquitin precursor UbC, a 9-mer of ubiquitin, enables identiﬁcation of polyubiquitin binding proteins. (A) Architecture of the
recombinant GST-UbC protein used for array screening, showing the nine repeats of ubiquitin that form the UbC ubiquitin precursor. (B) Puriﬁed GST or GST-UbC (0.1 μg) were
applied to membranes and overlaid with 10 μg of truncated (1–
^
200) or full-length (1–
^
419) His6-NEMO. Binding was only observed between full-length NEMO and GST-UbC. (C)
Truncated and full-length NEMO (0.1 μg) were immobilized on membranes and overlaid with 10 μg of GST or GST-UbC, followed by detectionwith anti-GST. Again, binding was only
observed between GST-UbC and full-length NEMO. (D) Detection of polyubiquitin binding proteins following macroarray probing with GST-UbC and detection with anti-GST-HRP.
Positive hits are visible as two duplicate spots on the array, labeled with the name of the expressed protein and the x,y coordinates used to identify the clones.
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123 SEAP (Clontech). HEK-293T cells in 24-well plates were transfected
124 with plasmids encoding either AWP1 (in pCMV6-Entry; OriGene),
125 RIO3 (in pCMV6; Imagenes) or optineurin (in pDEST26; [8]) and
126 400 ng of pNF-κB-SEAP for 24 h followed by treatment with TNFα
127 (100 ng/ml). Alternatively, cells were transfected with pNF-κB-SEAP
128 and 20 pmol of previously validated siRNAs against AWP1 (Santa Cruz
129 Biotech), RIO3 (Ambion) or scrambled control siRNAs. SEAP activity
130 was determined as described previously [11] using AttoPhos substrate
131 (Roche) and a BioTek Synergy HT plate reader.
132 2.6. IκBα degradation assay
133 HEK-293Tcells in 6-well plates were transfectedwith 10 μg of His6-
134 optineurin (positive control), AWP1, RIO3 or empty expression vectors
135 and incubated for 20 h. Cells were then treated with 5 ng/ml of TNFα
136 for 15 min, placed on ice and rapidly scraped into 200 μl of cell lysis
137 buffer (50 mM Tris–
^
HCl, 150 mM NaCl, 0.5% NP-40, protein inhibitor
138 cocktail, pH 8.0). Following a 30min incubation periodwith end-over-
139 end turning at 4°C, the lysates were centrifuged, supernatants
140 collected and mixed with equal volumes of Laemmli sample buffer.
141 Proteins were resolved by SDS-PAGE and IκBα detected with anti-
142 IκBα (Cell Signaling Technology).
143 3. Results
144 3.1. Ubiquitin C is a substrate for polyubiquitin binding proteins
145 To identify polyubiquitin binding proteins, we ﬁrst overexpressed
146 and puriﬁed human UbC, a ubiquitin precursor containing nine
147 repeats of ubiquitin [12], as a 106 kDa GST fusion protein (Fig. 1A). To
148validate the usefulness of GST-UBC as an array probe for polyubiquitin
149binding proteins, we spotted full-length recombinant NEMO (419 aa)
150and a truncated variant (1–
^
200 aa) lacking the coiled zipper required
151for ubiquitin binding [13] onto a membrane and probed with GST-UbC
152or GST, then detected binding using an anti-GST antibody. Binding
153occurred between full-length NEMO and GST-UbC (Fig. 1B), indicating
154that full-length NEMO bound the UbC moiety of the GST-UbC fusion.
155Similarly, when we spotted GST or GST-UbC onto the membranes and
156probed with full-length or truncated NEMO, the same interaction was
157observed (Fig. 1C). From this result we concluded that GST-UbC was a
158useful probe to search for polyubiquitin binding proteins.
1593.2. Polyubiquitin binding proteins are detected by membrane array
160screening
161We next used GST-UbC to probe a membrane-based colony
162macroarray for polyubiquitin binding proteins. The array used consists
163of a human cDNA library of approximately 8
^
300 unique GenBank gene
164accession numbers from brain, colon, liver and lung in an E. coli
165protein expression host, and has been used to successfully identify
166interactions between other proteins [9,14]. From two independent
167screens of the array with GST-UbC and a control screen using GST, we
168arrived at a ﬁnal dataset of 58 individual clones expressing 31 unique
169proteins (Table 1, Fig. 2). Of these proteins, 23 have previously been
170shown to bind polyubiquitin, including 10 proteins that are involved
171in the NF-κB pathway, namely NEMO, A20, ABIN-1, ABIN-2, Cbl-b, p62,
172optineurin, TOLLIP, TAX1BP1 and Ymer.
173The majority of expressed UbC binding proteins were not full-
174length proteins, enabling us to use the screen to identify regions of
175these proteins responsible for UbC binding (Table 1). Inspection of the
Table 1t1:1
Polyubiquitin binding proteins identiﬁed using colony macroarrays.
t1:2
t1:3 Gene name Protein name GenBank accession number Amino acid sequence span (full-length) Reference
t1:4 Previously identiﬁed ubiquitin interactors
t1:5 CBLB Cbl-ba NP_733762 725–982 (982) [24]
t1:6 CUEDC2 CUE domain-containing 2 NP_076945 6–287 (287) [25]
t1:7 EPN1 Epsin 1 EAW72408 182–576 (576) [26]
t1:8 EPN2 Epsin 2 NP_683723 55–584 (584) [26]
t1:9 GGA1 GGA1 NP_037497 187–639 (639) [27]
t1:10 HSJ1 HSJ1 neuronal DnaJ (Hsp40) homolog NP_006727 191–324 (324) [28]
t1:11 IKBKG NEMOa Q9Y6K9 190–419 (419) [29]
t1:12 NSFL1C NSFL1 cofactor p47 Q9UNZ2 1–370 (370) [30]
t1:13 OPTN Optineurina Q96CV9 309–577 (577) [8]
t1:14 PSMD4 26S proteasome regulatory subunit 4 P55036 221–377 (377) [31]
t1:15 hHR18 RAD18 AAF86618 152–495 (495) [32]
t1:16 RAD23A RAD23 NP_005044 159–363 (363) [33]
t1:17 SQSTM1 Sequestosome 1/p62a NP_003891 326–440 (440) [34]
t1:18 TAX1BP1 TAX1 binding protein 1a NM_006024 219–498 (789) [35]
t1:19 TNFAIP3 A20a NP_006281 705–790 (790) [36]
t1:20 TOLLIP Toll interacting proteina NP_061882 118–274 (274) [37]
t1:21 TNIP1 ABIN-1a NP_006049 266–636 (636) [7]
t1:22 TNIP2 ABIN-2a NP_077285 293–429 (429) [7]
t1:23 UBAP1 Ub-associated protein 1 Q9NZ09 399–502 (502) [38]
t1:24 UBL7 Ub-like protein 7 Q96S82 1–380 (380) [39]
t1:25 UBXN1 SAPK substrate protein 1 NP_056937 1–312 (312) [40]
t1:26 USP5 Ub-speciﬁc peptidase 5 NP_003472 623–835 (835) [41]
t1:27 CCDC50 Ymera AAH65004 1–306 (306) [42]
t1:28
t1:29 Novel interactors
t1:30 AWP1 Associated with protein kinase Ca CAG38507 1–208 (208) [43]
t1:31 CALCOCO2 Calcium binding coiled-coil domain 2 NP_694574 118–446 (446) [44]
t1:32 N4BP1 NEDD4 binding protein 1 NP_694574 209–896 (896) [45]
t1:33 RIO3 RIO kinase 3 O14730 16–153 (519) [46]
t1:34 TEX27 Testis-expressed sequence 27 NP_068762 1–227 (227) [47]
t1:35 TTC3 Tetratricopeptide domain containing 3 NP_003307 1824–2025 (2025) [48]
t1:36 UBFD1 Ub-binding family domain containing 1 NP_061989 126–309 (309) None available
t1:37 ZNF313 Zinc ﬁnger protein 313 Q9Y508 1–228 (228) [49]
A total of 31 UbC binding proteins were identiﬁed, with 23 known to have ubiquitin binding activity from previous work, and the remaining eight being novel binding proteins.
t1:38 a Proteins known to associate with or inﬂuence the activity of the NF-κB pathway (see References).9
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176 expressed regions and comparison with available literature revealed
177 that for each of the proteins the knownpolyubiquitin binding domains
178 were localized within the expressed regions. Given the abundance of
179 known polyubiquitin binding proteins that appeared in our screen, we
180 concluded that this approach was useful for the detection of
181 polyubiquitin binding proteins. We also found that this method is
182 useful for the localization of binding domains within polyubiquitin
183 binding proteins due to the fragmented nature of the arrayed proteins.
184 The group of novel interactors included AWP1, CALCOCO2, N4BP1,
185 RIO3, TEX27, TTC3, UBFD1 and ZNF313. One of these proteins, AWP1
186 (associated with PRK1) represses NF-κB-dependent transcriptional
187 activation when overexpressed [15], while the remainder are not
188 known to inﬂuence the NF-κB pathway.
189 3.3. Novel polyubiquitin binding proteins possess both typical and novel
190 polyubiquitin binding domains
191 Sequence analysis of the novel putative polyubiquitin binding
192 proteins revealed that AWP1, TEX27, TTC3 and ZNF313 possessed zinc
193 ﬁnger motifs (Fig. 2A) which, given their location within the
194 expressed protein fragments, may have mediated their binding to
195polyubiquitin substrates. AWP1 and TEX27 contain an N-terminal
196A20-like zinc ﬁnger and a C-terminal AN1-like ﬁnger, while TTC3 and
197ZNF313 contain RING-ﬁnger motifs. Of the remaining proteins,
198CALCOCO2 (calcium-binding coiled coil) possesses an N-terminal
199calcium-binding domain and a C-terminal region similar to the LIM
200zinc ﬁnger domain [16]. RIO3 possesses a C-terminal kinase domain,
201while UBFD1 contains the UBQ signature present in ubiquitin and
202related proteins (Fig. 2A). The absence of known polyubiquitin
203binding domains in these proteins suggests that they bind poly-
204ubiquitin through novel mechanisms.
2053.4. Novel polyubiquitin binding proteins interact with K48- and
2061212K63-linked polyubiquitin
207Under physiological conditions, UbC appears to be processed into
208ubiquitin monomers by a C-terminal hydrolase [17]. The monomers
209that arise are then used as substrates by E3 ligases for conjugation to
210proteins, typically as K48- or K63-linked polyubiquitin [18]. While
211other linkages, including K6, K11 and K27 do occur, to date only the
212linear, K48- and K63-linkage variants have been found in association
213with the NF-κB signaling pathway [19]. With this in mind, we next
Fig. 2. Novel polyubiquitin binding proteins possess conventional and novel polyubiquitin binding domains. (A) Each of the novel polyubiquitin binding proteins is represented with
relevant domains and the regions expressed on the macroarrays. Abbreviations used are: ZnF, zinc ﬁnger; CALCOCO, calcium-binding coiled coil; LIM, Lin11, Isl-1 and Mec-3; NYN,
NYN domain RNase; Di19, drought-induced protein 19; TTC, tetratricopeptide; UBQ, ubiquitin-like. The dotted lines indicate the region of the protein expressed by the vector when
full-length proteins were not expressed. (B) Novel polyubiquitin interacting proteins AWP1, N4BP1, RIOK3 and TTC3 bind to physiologically relevant forms of polyubiquitin in vitro.
Puriﬁed GST, GST-UbC, monoubiquitin and K48- and K63-linked polyubiquitin were spotted onto membranes and probed with puriﬁed RGS-His6-tagged polyubiquitin binding
proteins, followed by detection with anti-RGS-His6 antibody. (C) Full-length polyubiquitin binding proteins expressed in human cells bind UbC. Puriﬁed GST or GST-UbC bound to
glutathione sepharose beads were incubated with lysates from HEK-293T cells as indicated in the methods and bound protein detected with speciﬁc antibodies. (D) Protein staining
and immunoblotting of the GST and GST-UbC proteins used as input for GST pulldown experiments. Proteins were resolved by SDS-PAGE and detected by Coomassie staining or
immunoblotting with GST-HRP antibody.
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214 sought to determine if the novel polyubiquitin binding proteins could
215 bind to these two different forms of ubiquitin. We thus spotted UbC,
216 monoubiquitin, and either K48-linked or K63-linked polyubiquitin
217 onto membranes and performed an overlay assay with each of the
218 puriﬁed novel binders.
219 Full-length NEMO bound both K48- and K63-linked polyubiquitin
220 (Fig. 2B), as demonstrated by other workers [1]. Among the novel
221 interactors, AWP1 and RIO3, and to a lesser extent N4BP1 and TTC3,
222 bound to K63-linked polyubiquitin. Only AWP1 and RIO3 displayed
223 observable binding to K48-linked ubiquitin, similar to that observed
224 for NEMO (Fig. 2B). A visible lack of K48- and K63-linked
225 polyubiquitin binding by CALCOCO2, TEX27 and ZNF313 may be due
226 to their afﬁnity for other linkage variants of polyubiquitin, or possibly
227 due to a low afﬁnity for these forms of polyubiquitin which we were
228 unable to detect. None of the novel interactors displayed afﬁnity for
229 puriﬁed GST, which conﬁrmed that the interactions detected by array
230 screening were not the result of binding to this tag. Additionally, we
231 also noted that the yield of recombinant protein obtained from E. coli
232 for each of the interactors corresponded closely with the spot
233 intensities shown on the array, with highly expressed proteins (e.g.,
234 RIO3) having intense array spots and poorly expressed proteins (e.g.,
235 ZNF313) having relatively faint array spots. This ﬁnding suggests that
236 the original array screen was limited by E. coli protein expression
237 levels on the array rather than the amount of GST-UbC probe used for
238 screening.
239 3.5. Cell line-expressed novel interactors bind to UbC
240 We next investigated whether the polyubiquitin binding proteins,
241 expressed as full-length proteins in human cells, were able to bind to
242ubiquitin using a GST pulldown assay. Extracts from HEK-293T cells
243expressing the interactors were prepared and incubated with
244immobilized GST or GST-UbC, followed by SDS-PAGE and detection
245with speciﬁc antibodies. As shown in Fig. 2C, GST-UbC but not GSTwas
246able to bind each of the proteins which again conﬁrmed that the
247interactions detected by the array screening were not the result of
248binding to the GST tag. Samples of lysate from HEK-293T cells
249expressing the interactors (input) were used as positive controls for
250the presence of the polyubiquitin binders in the cells. The lack of a
251commercially available antibody or full-length clone of UBFD1
252prevented the investigation of this protein in these pulldown
253experiments. Validation of the input GST and GST-UbC proteins used
254for these pulldown experiments was performed by both Coomassie
255staining and immunoblotting. Both methods clearly revealed the
256presence of the expected 27 and 106 kDa protein bands corresponding
257to GST and GST-UbC, respectively (Fig. 2D).
2583.6. AWP1 and RIO3 modulate NF-κB signaling in human cells
259To investigate a potential role for the novel polyubiquitin
260interactors in NF-κB signaling, we overexpressed AWP1 and RIO3 in
261HEK-293Tcells andmonitored NF-κB activity in response to treatment
262with TNFα. The TNFα cytokine was chosen because of its well-
263characterized mode of action, which depends on polyubiquitination of
264RIP following activation of the TNF receptor. Over-expression of
265optineurin has previously been demonstrated to strongly suppress
266TNFα-induced NF-κB activation by competing with NEMO for
267polyubiquitinated RIP [8] and was used as a control in these
268experiments. Transfection of HEK-293T cells with plasmids encoding
269AWP1, RIO3 and optineurin yielded a clear dose-dependent increase in
Fig. 3. AWP1 and RIO3 modulate NF-κB activity. (A) HEK-293T cells were transfected with pNF-κB-SEAP and expression vectors for AWP1, RIO3 or His6-tagged optineurin (control),
with empty vector being added to equalize the amount of DNA used in transfection. Overexpression was conﬁrmed by immunoblotting cell lysates at 24 h post-transfection using
anti-AWP1, anti-RIO3 or anti-His6. (B) Determination of SEAP activity in cell culture supernatants following transfection. HEK-293T cells were transfected for 24 h prior to treatment
with TNFα (100 ng/ml) for a further 24 h. SEAP activity was measured and expressed as relative light units (RLU). Error bars represent standard deviation of at least three
independent determinations. Treatment with TNFα did not alter levels of transfected protein expression as determined by immunoblot (data not shown). (C) AWP1 and RIO3 are
required formaximal NF-κB transcriptional activation. HEK-293Tcells were transfectedwith pNF-κB-SEAP and 20 pmol of AWP1, RIO3 or scrambled (ctrl) siRNA, followed by addition
of TNFα at 24 h post-transfection. SEAP activities are expressed as a percentage of the scrambled siRNA control. Values represent the means of at least four determinations, with error
bars representing the standard deviations.
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F270 protein expression (Fig. 3A) that remained unaffected by the addition271 of TNFα (data not shown). Overexpression of both AWP1 and RIO3
272 substantially reduced reporter activity in both the presence and
273 absence of TNFα, similar to the repression seen when optineurin was
274 overexpressed (Fig. 3B).
275 While AWP1 and RIO3 negatively affected NF-κB transcriptional
276 activation when overexpressed, we were also interested to determine
277 if these proteins affected NF-κB signaling at physiological levels. We
278 therefore cotransfected HEK-293T cells with pNF-κB-SEAP and
279 synthetic siRNAs directed against either AWP1 or RIO3. In the absence
280 of TNFα, both the AWP1 and RIO3 siRNAs reduced reporter activity by
281 approximately 40% compared to scrambled control siRNAs (Fig. 3D).
282 In the presence of TNFα, AWP1 siRNA had little impact on NF-κB
283 reporter activity, while RIO3 siRNA reduced the reporter activity by
284 almost 30% compared to the control siRNA (Fig. 3D). Surprisingly,
285 these results indicated that both AWP1 and RIO3 are positive
286 regulators of NF-κB activity, despite our ﬁnding that both proteins
287 repress NF-κB activity when overexpressed.
288 To more clearly deﬁne how AWP1 and RIO3 inﬂuence NF-κB
289 activity, we next looked at whether these proteins could interferewith
290 the TNFα-dependent degradation of IκBα. As before, we used
291 optineurin, a known suppressor of IκBα degradation [8], as a control
292 protein. In the presence of the empty control vector, addition of TNFα
293 resulted in a clear reduction of IκBα (Fig. 4), while overexpression of
294 optineurin clearly suppressed this degradation as described pre-
295 viously [8]. Similarly, AWP1 and RIO3 overexpression had an obvious
296 effect of IκBα levels, reducing its TNFα-dependent degradation almost
297 as efﬁciently as optineurin. Thus, overexpression of both AWP1 and
298 RIO3 appears to inﬂuence IκBα activity in a similar way to a known
299 pUb-binding NF-κB suppressor.
300 4. Discussion
301 This study represents the ﬁrst use of protein arrays for the rapid
302 identiﬁcation of polyubiquitin binding proteins. Our screen using UbC
303 revealed 31 different polyubiquitin binding proteins, of which eight
304 were novel interactors. The majority of the identiﬁed interactors are
305 known from previous work to bind polyubiquitin, including proteins
306 known to modulate NF-κB signaling through their polyubiquitin
307 binding such as NEMO, optineurin, ABIN-1, ABIN-2 and A20, which
308 validates the usefulness of our screening method.
309 Among the novel polyubiquitin interactors, AWP1, TEX27, CAL-
310 COCO2, TTC3, UBFD1 and ZNF313 all possess domains that suggest an
311 interaction with ubiquitin, including zinc ﬁnger domains in AWP1,
312 TTC3 and ZNF313, and the LIM domain in CALCOCO2. Of particular
313 interest was the ﬁnding that RIO3, the third member of the RIO kinase
314 family, bound ubiquitin via a domain in the N-terminus of the protein.
315 Among the three known RIO kinases, the N-terminus of RIO3 is the
316 only one of previously unknown function [20]. RIO1 and RIO2 kinases
317possess
^
N-terminal helix-
^
turn-
^
helix domains that appear to mediate
318DNA binding and play a role in regulating ribosome biogenesis and the
319cell cycle [20]. Our ﬁnding that the N-terminal region of RIO3
320mediates polyubiquitin binding suggests a distinct function for this
321protein. The observation that RIO3 also binds K48- and K63-linked
322polyubiquitin and is required for maximal NF-κB activity suggests that
323this protein is an accessory of the NF-κB signaling pathway. RIO3 is
324ubiquitously expressed [21] and hence may represent an important
325new modulator of NF-κB signaling.
326Previous work has indicated that overexpressed AWP1 represses
327NF-κB mediated transcriptional activation [15], and an analysis of
328AWP1 domain structure provides obvious hints as to how this might
329occur. Of the zinc ﬁnger domains in AWP1 (see Fig. 2), the N-terminal
330domain belongs to the A20 family of zinc ﬁngers, of which the A20
331protein functions as a deubiquitinating enzyme that removes K63-
332linked polyubiquitin from RIP to suppress TNFα signaling. While
333AWP1 does not possess the cysteine protease domain that enables A20
334to deubiquitinate RIP, overexpressed AWP1 might instead compete
335with NEMO for K63-linked polyubiquitin, similar to optineurin [8].
336However, our ﬁnding that siRNA directed at endogenous AWP1 mRNA
337also reduced NF-κB activity suggests that AWP1 is a positive regulator
338of the NF-κB pathway under physiological conditions. The apparent
339contradiction in results for both RIO3 and AWP1 when comparing
340overexpression with siRNA knockdown is difﬁcult to explain as the
341biological functions of these proteins remain unknown. However, it is
342interesting to note that NEMO overexpression leads to dramatic
343repression of NF-κB signaling [22,23], which is counterintuitive given
344that siRNA knockdown or genetic knockout of NEMO completely
345ablates NF-κB activity. Previous workers have suggested that this
346paradox is due to misregulation [22,23] that occurs following
347overexpression, which may explain our results. One conclusion we
348can make, however, is that AWP1 and RIO3 do not function in the
349same way as optineurin, whose knockdown by siRNA leads to
350dramatically enhanced NF-κB activity [8], while AWP1 and RIO3
351knockdown reduces NF-κB activity somewhat. Future work will be
352required to determine at what step in the NF-κB signaling pathway
353AWP1 and RIO3 exert their effects.
354While numerous known polyubiquitin binding proteins were
355identiﬁed in this screen, it is likely that many other binders were not
356identiﬁed in this screen due to a poor or reversible afﬁnity for
357polyubiquitin or UbC in particular, or incomplete and insoluble
358expression in E. coli prior to screening of the arrays. Additionally, the
359arrays used represent only a fraction of the human proteome and we
360thus cannot conclude that the identiﬁed binders represent the bulk
361of such proteins in human cells. However, the identiﬁcation of such a
362large number of known NF-κB regulators is quite compelling in
363terms of the usefulness of this screen for this subgroup of
364polyubiquitin binding proteins. Moreover, the recent discovery by
365Tokunaga et al. [19] that conjugation of linear polyubiquitin chains to
366NEMO regulates canonical NF-κB signaling appears to increase the
367relevance of our screen using UbC, a linear form of polyubiquitin.
368Proteins such as RIO3 and AWP1 would, given their UbC binding
369activity, be able to interact with these linear polyubiquitin chains
370linked to NEMO and may inﬂuence NF-κB signaling via this
371interaction.
372In short, we have demonstrated here that UbC is a useful bait
373protein for the rapid detection of polyubiquitin binding proteins using
374protein arrays and has enabled the identiﬁcation of both known and
375novel regulators of NF-κB activity, which is a key to the control of
376immune responses, differentiation and survival of most eukaryotic
377cells.
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